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            The loss of consciousness has been a subject of wonder and uncertainty in humans, and 
for this reason it has been the object of medical investigation since the beginning of time. Even 
actually, it is certainly an unresolved clinical problem. Many centuries ago, complicated 
exorcisms   and   remedies   were   used   on   these   unfortunate   patients,   who   upon   regaining 
consciousness would find themselves soaked in miraculous liquids, ingesting curative potions, 
and often on the way to be burned accused of being possessed. In the seventeen century, 
physicians began to relate loss of consciousness and haemodinamic changes. William Harvey 
was perhaps the first to describe a circulatory response (vasovagal reaction) during a phlebotomy 
in the year 1628: “...Yet it fear or any other cause, or something do intervene through passion of 
the mind, so that the heart do beat more faintly, the blood will be no means pass through but 
drop after drop…”1. During the nineteenth century, loss of consciousness was the object of 
studies and research, and the vagally mediated cardioinhibition, as a primary cause, was noted by 
Foster who proposed that profound bradycardia diminished cerebral perfusion to a level 
inadequate to maintain consciousness2. At this time, it was reported the first use of the tilt-table 
test3. Commonly referred to as fainting or loss of consciousness, from last century the preferred 
medical term is syncope, which itself is derived from the Greek term “syncoptein” meaning “to 
cut short”. Syncope is defined as the sudden loss of consciousness and postural tone with 
spontaneous recovery. In 1907, Gowers was the first person to use the term vasovagal syncope4. 
In 1918 was published the work in which Cotton and Lewis described for the first time the 
clinical characteristics that are still used today to recognize the syncopal reaction5. However, it 
was not till 1932 when Lewis described this reaction as being characterized by a combination of 
bradycardia, hypotension, and syncope, and he coined the term vasovagal syncope for the first 
time6. 
            From the first studies with patients suffering loss of consciousness, it was observed that 
they all suffered a haemodynamic collapse which, though poorly understood initially, was 
analyzed with the diagnostic methods of the time period. In the past, those patients with 
recurrent syncopes were often subjected to a long, tedious, expensive, and all too often fruitless 
routine series of tests aimed at disclosing a potential aetiology. It was not until 1957 that one of 
the pioneering works on the use of the tilt-table test on such patients was published. In this work 
with university students, Weissler et al. tilted the individuals to 60º and observed 20% positive 
(abnormal) results. They induced  syncope in others  by  oral   administration  of  sodium   nitrate
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10-15 minutes before the test7. After studying patients with syncope of unknown aetiology and 
based on the known induction of a vasovagal response in young adults8,9 as well as the results of 
aerospace studies10-15, a group of English cardiologists conducted by Kenny and Sutton in 1986 
published the first research paper on tilt testing16. In this Landmark study, they used the tilt-table 
test at an angle of 40º for 60 minutes on 15 patients with syncope of unknown aetiology, and on 
10 control individuals. Nine of 15 patients (67%) and 1 control developed syncope during tilt.    . 
From the time of this historic work to the present day, more than 830 papers have been published 
in which the keyword is vasovagal syncope and more than 975 with the term tilt-table test. 
            There is no question that this technique has helped for the understanding of the vasovagal 
syncope and its pathophysiology. However, many authors currently question this technique due 
to the many concerns that still need to be resolved: 
1) Are clinical and induced vasovagal syncope equivalent?
2) Is a tilt-table test indicated in all patients with vasovagal syncope?
3) Is there a standardized protocol?
4) What is the result of a tilt-table test?
5) Is the tilt-table test useful for anything other than diagnostics?
6) Exist complications of the test?
Correlation Between Clinical Syncope And Induced Syncope
             In Medicine, many doubts exist regarding induced phenomena. Physicians should 
question the correlation between clinically spontaneous and induced results. Furthermore, is the 
clinical phenomenon reported by the patient equivalent to the induced? In the case of vasovagal 
syncope, it seems to be clear that they are equivalent. We can base this conclusion on three 
fundamental facts:
A) Spontaneous syncope and induced syncope in the tilt-table test are associated with similar 
premonitory signs and symptoms.  The most characteristic premonitory symptoms that are 
almost always described by patients are nausea, redness, perspiration, and abdominal discomfort. 
Clinical signs include marked pallor, bilateral mydriasis, and loss of postural tone17-19.
B) The temporal sequence of changes in blood pressure and heart rate during induced 
syncope parallel those seen with spontaneous syncope. Though earlier data from European 
studies placed doubt on this conclusion20, it has been shown that in patients suffering from 
syncope, there was a demonstrable and reproducible neurovegetative imbalance21,22. This was 
manifested as an increase in central sympathetic stimulation preceding syncope23 associated with 
a very acute decrease in cardiac output and a later drop in mean arterial pressure, as a result of 
the  parasympathetic  nervous   activity  and  peripheral   resistance24  measured  by  means   of 
microvascular Doppler with a decrease in subcutaneous blood flow25.
C) Plasma catecholamine levels measured before and after spontaneous and induced syncope 
are very similar. Above all, an increase in circulating catecholamines has been shown both in 
spontaneous syncope in the upright position26-29 and in induced syncope with the tilt-table test30, 
with maintained levels of norepinephrine and a five-fold increase in epinephrine levels31, and 
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with intervention of endogenous opioids and differences between experimental protocols32.
Who Should Undergo Tilt-Table Testing? 
            The ACC expert consensus document for tilt-table testing was published in 1996 with 
this summary of principals indications17  divided into three general categories depending its 
warranty:
Tilt table testing is warranted:
1) If recurrent syncope or single syncopal episode in a high risk patient have occurred, whether 
or   not   the   medical   history   is   suggestive   of   neurally   mediated   (vasovagal)   origin,   and
1.1 No evidence of structural cardiovascular disease.                                          
1.2 Structural cardiovascular disease is present, but other causes of syncope have been excluded 
by   appropriate   testing.                                                                                  
2) For further evaluation of patients in whom an apparent cause has been established (e.g. 
asystole, atrioventricular block), but in whom demonstration of susceptibility to neurally 
mediated syncope would affect treatment plans.                                                 
3) Parts of the evaluation of exercise-induced or exercise-associated syncope.                          
Reasonable   differences   of   opinion   exist   regarding   utility   of   tilt   table   testing   for:
1) Differentiating convulsive syncope from seizures.                                                     
2) Evaluating patients (especially the elderly) with recurrent unexplained falls.                     
3) Assessing recurrent dizziness or presyncope.                                                                         
4) Evaluating unexplained syncope in the setting of peripheral neuropathies or dysautonomies
5) Follow-up evaluation to asses therapy of neurally mediated syncope                        
Tilt table test is not warranted after:                                                                               
1) Single syncopal episode, without injury and not in a high risk setting with clear-cut vasovagal 
clinical features.                                                                                                     
2) Syncope in which an alternative specific cause has been established and in which additional 
demonstration   of   a   neurally   mediated   susceptibility   would   not   alter   treatment   plans. 
Potential   emerging   indications   are:                                                                    
1) Recurrent idiopathic vertigo                                                                                                 
2) Recurrent transient ischemic attacks                                                                                     
3) Chronic fatigue syndrome                                                                                             
4) Sudden Infant Death Syndrome (SIDS)                                                                                 
        Later, and following the same kind of recommendations (class I, II and III), the European 
Society of Cardiology33 published its guidelines in 2001. They recommended:                            
Indications
Class I:                                                                                                                                     
Tilt testing is indicated for diagnostic purposes:                                                                 
1) In cases of unexplained single syncopal episodes in high risk settings (e.g. occurrence of, or 
potential risk for, physical injury or with occupational implications), or recurrent episodes in the 
absence of organic heart disease, or, in the presence of organic heart disease, after cardiac causes 
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of syncope have been excluded.                                                                          
2) When it will be of clinical value to demonstrate susceptibility to neurally-mediated syncope to 
the patient.                                                                                                                         
Class II:                                                                                                                                 
Tilt testing is indicated for diagnostic purposes:                                                                    
1) When an understanding of the haemodynamic pattern in syncope may alter the therapeutic 
approach.
2) For differentiating syncope with jerking movements from epilepsy.                                          
3) For evaluating patients with recurrent unexplained falls.                                           
4) For assessing pre-syncope or dizziness.                                                              
Class III:                                                                                                                                     
1) For assessment of treatment.                                                                                                             
2) A single episode without injury and not in a high risk setting                                    
Diagnosis
Class I:                                                                                               
1) In patients without structural heart disease, tilt testing can be considered diagnostic, and no 
further   test   needs   to   be   performed   when   spontaneous   syncope   is   reproduced.
2) In patients with structural heart disease, arrhythmias or other cardiac causes should be 
excluded prior to considering positive tilt test results as evidence suggesting neurally mediated 
syncope.
Class II:                                                                                                                                                     
The clinical meaning of abnormal responses other than induction of syncope is unclear.
Is There A Standarised Protocol?                                                                                       
            Since the first published work16, numerous papers have been written on the methodology 
of this test that have increased our understanding of the pathophysiology of vasovagal syncope. 
Various   protocols   have   been   proposed   in   the   literature   and   are   explained   below:
Basal or Westminster Protocol:  In 1991, a group at the Westminster Hospital of London 
published their methodology showing the greater specificity of the test performed on a table with 
footboard support at an angle of 60º for 45 minutes without intravenous cannulation or infusion 
of vasoactive substances. They described a sensitivity of 75% and a specificity of 93%34. Doubts 
exist about the duration that should be used during tilt testing. To address this question, Stein et 
al analyzed data from 11 published studies using this protocol and performed tilt testing on 213 
patients for 30 to 60 minutes. They demonstrated that diagnostic accuracy is not greatly 
influenced by duration of the test after 30 minutes, varying from 60% to 84%35. Furthermore, 
this protocol has been used less and less, in spite of what was initially described, since the true 
sensitivity appears to be lower. In a study of more than 1,000 consecutive patients, our group 
found a sensitivity of 24.4% but with a significant decrease with age. Thus, the rate of positive 
responses in young subjects (<20 years old) was 41% but it decreased to only 19% in subjects 
older than 60 years (p<0.05)36.                                                                                               
Isoprenaline Protocol: Mainly proposed by North American authors, this method consists of an 
initial phase of tilting without drug administration and a later phase in which isoprenaline is 
administered by intravenous infusion at different rates, using an angle of 70-80º. Between the 
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various suggested protocols using this drug, one of the most commonly used is the published by 
Almquist37. In this, following a basal phase of 10 minutes of tilting at 80º, progressive doses 
from 1 to 5 mg/min of isoprenaline are infused. This method results in a sensitivity of 87% and a 
specificity of 85%. Other authors have criticized this protocol reporting lower sensitivity (75%) 
and lack of specificity38. This, in addition to secondary effects later described, led to the use of 
lower doses. Morillo et al39 advocate this, and achieved a sensitivity of 61% and a specificity of 
93%. Other authors have compared high and low doses of this substance and achieved better 
results with low doses (2 mg/min), with a sensitivity of 64% and specificity of 88.9%40. With the 
intention to reduce the long necessary time for this technique, a protocol using this substance 
was recently published in which the basal phase is eliminated, using only the isoprenaline 
phase41.  
Edrophonium Protocol:  After a 45-minute basal phase, a 10 mg intravenous bolus of this 
substance has been used and tilting is prolonged for another 20 minutes42. These authors found a 
high rate of positive responses at two different angles (60º and 80º). Since this study used a 
femoral arterial catheter, the results may be questioned and certainly no other group has reported 
experience with this protocol.                                                                                                               
Clomipramine Protocol: A group in Greece recently reported the use of this protocol without a 
basal phase, infusing 5 mg of this substance intravenously, and holding the table for 20 
minutes43,44. This protocol resulted in a sensitivity of 80% and a specificity of 95.4%.
Nitroglycerine Protocol (Italian Protocol): In 1994 Raviele et al. studied in 40 patients with 
syncope and 25 controls with previous negative tilt-table test results, a new protocol at 80º using 
intravenous nitroglycerine. They reported a sensitivity of 53% and a specificity of 92%45. 
Several years later, this author used a 60º angle for 45 minutes followed by sublingual 
administration of 300 mg. nitroglycerine followed by 20 minutes of further tilt testing to analyze 
the response of 235 patients and 35 controls. This method yielded a sensitivity of 51% and a 
specificity of 94%46. Later works were published47-51  until the definitive publication of the 
Italian protocol52, which recommends 20 minutes of tilting at 60º without drugs and without 
cannulation of peripheral veins. This was followed by an infusion of 400 mg of nitroglycerine 
sprayed sublingually, followed by 15 minutes of tilting. This protocol yielded a sensitivity of 
62% and a specificity of 92%. We recently reported our experience with this protocol based on 
data of 426 patients (sensitivity of 67,5%; specificity of 85.7%)53.                                          
            In view of all these data, we may conclude that there is not a standardized protocol for tilt 
test. However, for selection of a tilt test protocol, one should take into consideration that while 
the protocol without drugs (Westminster) has shown the highest specificity, the low sensitivity of 
this method suggests as necessary to use a drug induction phase. North American authors have 
preferred to use isoprenaline while most Europeans use nitroglycerine. Both strategies are valid 
since   when   both   protocols   are   compared   (randomly)   similar   results   are   achieved54,55.
General recommendations independent of protocol: The test should be performed in a quiet 
room with the lights slightly dimmed. Although the broad majority of groups report to perform 
the test during the morning, obviously, it may be undertaken during afternoon or at the evening. 
However, circadian patterns might influence the results of the test. It is important that the patient 
has fasted at least 2 hours before the test. In order to reduce the probability of a vasovagal 
response to venous cannulation, it has been proposed that patients remain in a supine position for 
20 to 45 minutes before the test. Based on specificity reduction observed with cannulation56, 
some protocols avoid its use and thus, supine position should be reduced to 5 minutes in those 
cases. Arterial blood pressure should be measured continuously. It is, therefore, recommended to 
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use beat-to-beat non-invasive blood pressure measurement systems. Intra-arterial cannulation has 
sometimes been used, but this can modify the specificity of the test in children and the elderly33. 
Intermittent measurements with a sphygmomanometer have been widely used. Although it is not 
the most desirable method, the price of continuous measurement devices makes it very 
commonly used in clinical practice. When performing the test, it should be possible to tilt the 
patient to the desired angle smoothly and rapidly, and it should also be possible to return quickly 
to a supine position (<10 sec.) when the test is terminated to avoid the consequences of a very 
prolonged loss of consciousness33. Our group has shown that the duration of time for changing 
to Trendelenburg position can have a negative influence on the duration of asystoles observed in 
some patients during the test (Figure 1). For this reason, we recommend that the necessary time 
from head-up tilt to Trendelenburg should be as short as possible57. Tilt tables should be 
equipped with footboard supports. An experienced nurse or technician should be continuously 
present during the test. The need to have a physician continuously present during the test has not 
been well established. However, since the risk for the patient during the test is very low, it seams 
to us as sufficient that physicians should be nearby and immediately available if a problem 
arises. 
 
Figure1: Continuous ECG trace of syncope development during 
HUT.  Top:  Baseline ECG before Tilting.  Bottom:  Continuous 
ECG   beginning   with   bradycardic   sinus   rhythm   followed   by 
asystole and occasionally occurring escape rhythm and beats (*) 
induced by vigorous blows to the precordium. The bradycardic 
arrhythmic   events   reverted   to   sinus   tachycardia   during 
Trendelemburg position and after atropine.
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Figure 2:  Continuous ECG trace of syncope development during HUT. After 
symptom initiation, 15 sec. of relative bradycardia is abruptly followed by a 31 
sec. asystole period. After tilt toward Trendelenburg position, patient presented 
tonic-clonic movements and muscular jerks.                                                 
What Are The Results Of A Tilt-Table Test?                                            
            When a patient undergoes a tilt-table test, two main responses may be observed. The first 
is a normal or negative response, which is defined as slight fluctuations in systolic and diastolic 
blood pressure and in heart rate, without any other abnormalities. The other response is the 
abnormal or positive response, which is characterized by a loss of consciousness following 
various haemodynamic patterns. Although vasovagal syncope is the diagnostic objective of the 
test, from the first studies it has been observed that there are others different positive responses 
(Table 1).58                                                                                                 . 
             Based on changes in arterial blood pressure and heart rate preceding the vasovagal 
reaction,  different  patterns  have  been  recognized.  Overall,   two  of   these  are  seen  most 
commonly33. The typical or classic pattern is characterized by a rapid and complete initial reflex 
phase of adaptation to the upright position with a stabilization of blood pressure and heart rate 
(which suggests normal baroreflex function) that lasts until the rapid onset of the vasovagal 
reaction (Figure 2). Patients exhibiting this kind of pattern tend to be young and healthy. They 
have a history of multiple syncopal episodes over many years. In many cases the first syncopal 
episode occurred at the age of 10 to 15 years. Secondary trauma is uncommon in those patients. 
This pattern represents a hypersensitive autonomic nervous system that responds excessively to 
various stimuli. On the other hand, a different pattern is often observed which is characterized by 
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an inability to achieve adaptation to the upright position. This results in a progressive drop in 
arterial blood pressure and heart rate, which occurs until symptoms appear. This is the so-called 
hypotensive pattern, in which the cause of symptoms appears to be the inability to adapt to 
external influences (hyposensitive autonomic nervous system function). Patients who show this 
kind of response tend to be elderly and have (many) associated diseases. They have a short 
history of syncope with few episodes per patient. The syncopal episodes begin later in life, 
suggesting that they occur as a result of some underlying progressive dysfunction. This pattern is 
similar to the pattern observed in patients with autonomic nervous system dysfunction and 
suggests the existence of a superimposition of the typical vasovagal syncope and other more 
complex pathological conditions of the autonomic nervous system. The tilt-table test can be 
useful in differentiating between these two syndromes. 
Table 1. Type of positive response during the tilt-table test58
            The typical or classic positive response has been initially classified as vasodepressor, 
cardioinhibitory, and mixed. The occasional appearance of asystoles during this typical response 
prompted to Sutton et al in 1992 to use the details of the haemodynamic response to the test to 
propose a classification scheme which has been recently modified and it has become an easy and 
useful tool59,60 (Table 2).                                                                
            The decision of when to terminate the test will influence the type of response that is 
observed. For this reason, it is recommended that in order to ensure correct classification of the 
response, the test should be terminated at the same moment that consciousness and postural tone 
are lost (when syncope occurs). A premature interruption will result in underestimation and a 
delayed termination will result in an overestimation of the cardioinhibitory response and will 
expose the patient to the consequences of a prolonged loss of consciousness. However, there has 
not been a consensus on this subject, and many physicians feel that it is sufficient to terminate 
the test when a sustained drop in blood pressure is observed simultaneously with symptoms.
Is The Tilt Test Useful For Anything Other Than Diagnostics?                               
             Evaluation of the response to treatment: Many authors have attempted to show the 
benefits of the various proposed treatments for vasovagal syncope evaluating their ability to 
produce a negative result on a patient who had previously presented a positive response to the 
test (ACC Class II recommendation in 199617. However, this has been criticized33,61,62. In order 
to use the test for evaluation of therapeutic options, two conditions need to be fulfilled: the test 
and a positive response to the test must be highly reproducible and must have high predictive 
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value of later outcome. Reproducibility of the tilt-table test has been widely studied. Overall, 
reproducibility of an initial negative response (85%-94%) is greater than it is for a positive 
response (31%-92%). Furthermore, data from controlled studies show that approximately 50% of 
patients with a positive basal test result will present a negative test if it is repeated under 
treatment or with a placebo63. Additionally, short-term studies are not predictive of the long-
term outcome under therapy (such as definitive stimulation). Thus, actual data show that the use 
of this test to evaluate the effectiveness of different treatments is subject to significant 
limitations33.
Table 2: Classification of positive responses to tilt testing60
Usefulness as therapy: Based on the above mentioned tendency of response negativization after 
repeated test, and due to the absence of any fully effective treatment for vasovagal syncope, 
various authors have proposed the use of the tilt-table test as a form of therapy for vasovagal 
syncope, the so-called “tilt training”64,65. These authors propose the use of the upright position 
supported against the wall for short and repeated time periods on successive days to train the 
body to withstand the upright position, thus significantly reducing the recurrence of syncope.
Complications
            The tilt-table test is a safe procedure, and the occurrence of complications is very low. 
Although extremely prolonged asystolic pauses have been reported, the occurrence of these 
asystoles during a positive response cannot be considered a complication since this is an end-
point of the test57,60. A rapid return to a supine position (or better to a Trendelemburg position), 
as soon as syncope occurs, is usually enough to prevent or limit the consequences of a prolonged 
loss of consciousness, however brief resuscitation maneuvers are occasionally required66. 
Complications have not been reported in relation to the Westminster protocol or with the use of 
nitroglycerine, but minor side effects occur commonly and include palpitations with the use of 
isoprenaline and headaches with nitroglycerine. However, using isoprenaline protocols, high 
doses of the drug are well tolerated in only 62% of patients, must be reduced in 33% and 
discontinued in 4.2%. Side effects include tachycardia (45%), nausea (35%), chest pain (2.2%), 
arrhythmias (6%), and other effects (10.3%)67. Vasospasm has been described several times with 
the use of this substance68. Life-threatening ventricular arrhythmias have been described with 
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isoprenaline in the presence of ischemic heart disease or sinus dysfunction. Atrial fibrillation can 
be   induced   during   or   after   a   positive   tilt   test   and   is   usually   self   limiting.
Conclusions
            Vasovagal syncope is the most frequent form of syncope of unknown aetiology. Since 
1986, the tilt-table test has become an important tool in the diagnosis of vasovagal syncope. 
Before this test was introduced, several patients were submitted to a multitude of tests although 
most of them did little more than waste of resources. The similarity between clinical and induced 
vasovagal syncope during the test shows its value. The tilt-table test yields a range of positive 
results from 60% to 70%, with a specificity greater than 85%. The results are also highly 
reproducible (data similar to provocation diagnostic tests such as the treadmill test) when drug-
based protocols are used. This, with the absence of serious complications and very small number 
of side effects, makes probably the nitroglycerine protocol as the actually most recommended 
test for clinical practice.                                                                                                       
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